We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Linde
LIN
$234B
| $1.58M | 0.01% |
3,368
-2,295
| -41% | -$1.05M |
|
652
Evergy
EVRG
$19.8B
| $1.58M | 0.01% |
22,916
+757
| +3% | +$50.9K |
|
653
CALL
Canadian Natural Resources
CNQ
$93.8B
| $1.58M | 0.01% |
+50,200
| New | +$1.52M |
|
654
PUT
Alcoa
AA
$11.7B
| $1.58M | 0.01% |
53,400
+15,100
| +39% | +$408K |
|
655
CALL
BridgeBio Pharma
BBIO
$16.5B
| $1.57M | 0.01% |
36,400
| – | – |
|
|
B
656
PUT
Barrick Mining
B
$62.1B
| $1.57M | 0.01% |
+75,300
| New | +$1.47M |
|
657
Zai Lab
ZLAB
$2.11B
| $1.54M | 0.01% |
44,070
-18,409
| -29% | -$605K |
|
658
Amprius Technologies Warrants
AMPX.WS
$370M
| $1.53M | 0.01% |
2,945,895
+479,341
| +19% | +$180K |
|
|
LCCCU
659
Lakeshore Acquisition III Corp Unit
LCCCU
| $1.53M | 0.01% |
+150,000
| New | +$1.51M |
|
660
PUT
Lockheed Martin
LMT
$135B
| $1.53M | 0.01% |
+3,300
| New | +$1.54M |
|
661
CALL
Shell
SHEL
$240B
| $1.51M | 0.01% |
21,500
-4,900
| -19% | -$328K |
|
662
PUT
The Mosaic Company
MOS
$7.1B
| $1.5M | 0.01% |
41,200
| – | – |
|
663
PUT
DraftKings
DKNG
$12.1B
| $1.48M | 0.01% |
34,500
-47,100
| -58% | -$1.69M |
|
664
CALL
GameStop
GME
$9.61B
| $1.46M | 0.01% |
+60,000
| New | +$1.61M |
|
665
Moderna
MRNA
$22.1B
| $1.46M | 0.01% |
52,753
+41,353
| +363% | +$1.09M |
|
666
Codere Online Luxembourg Warrants
CDROW
$5.79M
| $1.45M | 0.01% |
1,424,161
| – | – |
|
|
667
CALL
Alcoa
AA
$11.7B
| $1.45M | 0.01% |
49,100
+14,900
| +44% | +$402K |
|
|
668
CALL
The Mosaic Company
MOS
$7.1B
| $1.45M | 0.01% |
39,700
+13,100
| +49% | +$420K |
|
669
PUT
Suncor Energy
SU
$75.6B
| $1.43M | 0.01% |
38,300
| – | – |
|
670
Algoma Steel Group Warrant
ASTLW
$239K
| $1.43M | 0.01% |
2,808,732
| – | – |
|
671
PUT
Datadog
DDOG
$90.8B
| $1.42M | 0.01% |
10,600
-16,500
| -61% | -$1.83M |
|
|
672
PUT
Moderna
MRNA
$22.1B
| $1.42M | 0.01% |
51,400
-18,800
| -27% | -$495K |
|
673
PUT
Chevron
CVX
$381B
| $1.42M | 0.01% |
9,900
-16,000
| -62% | -$2.26M |
|
674
Skyworks Solutions
SWKS
$9.43B
| $1.41M | 0.01% |
18,905
+12,492
| +195% | +$834K |
|
675
CALL
General Motors
GM
$77.3B
| $1.4M | 0.01% |
28,400
-248,500
| -90% | -$11.8M |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.